Thomas L Holland

Also affiliated with Clinical Research Institute

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 34 papers. Top paper: “Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial”.

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00215-6

N/A

4.5DataRank · unranked

128 citations

Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits +95 more

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels

Annals of Internal Medicine(2021)10.7326/m21-3507

N/A

3.8DataRank · unranked

76 citations

Jens Lundgren, Birgit Grund, Christina E. Barkauskas, Thomas L Holland, Robert L. Gottlieb +88 more

Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study

Clinical Infectious Diseases(2023)10.1093/cid/ciad599

N/A

2.4DataRank · unranked

62 citations

Roy F. Chemaly, Sanjeet Dadwal, Joshua A. Hill, Yeon Joo Lee, Ghady Haidar +32 more

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

Critical Care(2022)10.1186/s13054-022-04204-9

N/A

2.1DataRank · unranked

94 citations

Bruno François, Marc Bourgeois, Apostolos Komnos, Ricard Ferrer, Galia Rahav +94 more

Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial

Clinical Microbiology and Infection(2025)10.1016/j.cmi.2025.02.002

N/A

0.204DataRank · unranked

2 citations

Gregory Grandits, Lianne Siegel, Nicole Engen, Christina E. Barkauskas, Nnakelu Eriobu +25 more

Antibacterial Resistance Leadership Group 2.0: Back to Business

Clinical Infectious Diseases(2021)10.1093/cid/ciab141

N/A

0DataRank · unranked

13 citations

Scott Evans, Robin Patel, H. R. Cross, Anthony Harris, Yohei Doi +10 more

Of Rats and Men, a Translational Model to Understand Vancomycin Pharmacokinetic/Toxicodynamic relationships

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.22.437975

N/A

0DataRank · unranked

0 citations

Gwendolyn Pais, Thomas P. Lodise, Steven Y. C. Tong, Joshua S. Davis, J. Nicholas O’Donnell +8 more

Persistent methicillin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management

Clinical Infectious Diseases(2022)10.1093/cid/ciac364

N/A

0DataRank · unranked

46 citations

Arnold S. Bayer, Vance G. Fowler, Thomas L Holland

Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials

Clinical Infectious Diseases(2022)10.1093/cid/ciac692

N/A

0DataRank · unranked

40 citations

Toshimitsu Hamasaki, Weixiao Dai, Deborah Collyar, Daniel B. Rubin, Sumathi Nambiar +12 more

A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac140

N/A

0DataRank · unranked

19 citations

Weixiao Dai, Dafna Yahav, Toshimitsu Hamasaki, ‪Adi Turjeman‬‏, Fidi Koppel +11 more

Determination of plasma protein binding of dalbavancin

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac131

N/A

0DataRank · unranked

15 citations

Allan Xu, Smitha Zaharoff, Thomas L Holland, Thomas P. Lodise, Nicholas A. Turner

Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

Open Forum Infectious Diseases(2022)10.1093/ofid/ofab651

N/A

0DataRank · unranked

12 citations

Marc H. Scheetz, Joseph J. Carreno, Henry F. Chambers, Vance G. Fowler, Thomas L Holland +1 more

PROPHETIC EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit in European and United States Cohorts

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac231

N/A

0DataRank · unranked

1 citations

Sara B. Calvert, John Farley, Jie‐Lena Sun, Karen Chiswell, Willem Dieperink +16 more

223. Development and Analysis of a Novel DOOR Endpoint for Complicated Intra-abdominal Infections (cIAI) Using 10 Registrational Trials for Antibacterial Drugs

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac492.301

N/A

0DataRank · unranked

0 citations

Ramya Gopinath, Ursula Waack, Mark Needles, Daniel L. Rubin, Deborah Collyar +11 more

Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs

Clinical Infectious Diseases(2023)10.1093/cid/ciad239

N/A

0DataRank · unranked

23 citations

Ramya Gopinath, Ursula Waack, Mark Needles, Daniel B. Rubin, Deborah Collyar +11 more

Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Clinical Infectious Diseases(2023)10.1093/cid/ciad576

N/A

0DataRank · unranked

18 citations

Toshimitsu Hamasaki, Weixiao Dai, Deborah Collyar, Daniel B. Rubin, Sumathi Nambiar +24 more

The Future Ain’t What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations

Clinical Infectious Diseases(2023)10.1093/cid/ciad538

N/A

0DataRank · unranked

13 citations

Robin Patel, Toshimitsu Hamasaki, Jessica Howard‐Anderson, Tori Kinamon, H. A. King +36 more

The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions

Clinical Infectious Diseases(2023)10.1093/cid/ciad475

N/A

0DataRank · unranked

9 citations

H. R. Cross, Maria Souli, Scott Evans, Robin Patel, Vance G. Fowler +60 more

Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review

Clinical Infectious Diseases(2023)10.1093/cid/ciad565

N/A

0DataRank · unranked

6 citations

César A. Arias, Deena R. Altman, Ahmed Babiker, Helen W. Boucher, C. Buddy Creech +40 more

External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis

Clinical Infectious Diseases(2024)10.1093/cid/ciae033

N/A

0DataRank · unranked

42 citations

Patrick M. Bossuyt, David T. Durack, Larry M. Baddour, Arnold S. Bayer, Emanuele Durante‐Mangoni +9 more

Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing Among Immunocompromised Patients With Pneumonia

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae425

N/A

0DataRank · unranked

10 citations

Roy F. Chemaly, Sanjeet Dadwal, Joshua A. Hill, Yeon Joo Lee, Ghady Haidar +35 more

Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs

Clinical Infectious Diseases(2024)10.1093/cid/ciae163

N/A

0DataRank · unranked

4 citations

Ursula Waack, Mark Needles, Daniel B. Rubin, Deborah Collyar, Sarah B. Doernberg +11 more

Leadless pacemaker infective endocarditis: a case report and review of the literature

Clinical Microbiology and Infection(2024)10.1016/j.cmi.2024.05.023

N/A

0DataRank · unranked

4 citations

Emily Niehaus, Vance G. Fowler, Thomas L Holland, Ahmad Mourad

Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.485

N/A

0DataRank · unranked

1 citations

Rubria Marines‐Price, Olga Milman, Danae Deal, Jonathan Marchand, Jessica Linton +7 more

Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)

UNC Libraries(2024)10.17615/qngy-0518

N/A

0DataRank · unranked

0 citations

Yunyun Jiang, Helen W. Boucher, Paterson D.L., van Duin D., Dean Follmann +13 more

A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilities

Scientific Reports(2025)10.1038/s41598-025-04918-0

N/A

0DataRank · unranked

5 citations

Dana K. Pasquale, Heather Henderson, Eric Cober, Sandra S. Richter, Robert A. Salata +42 more

Interagency Collaboration for Patient-Centered Antibacterial Drug Development

Clinical Infectious Diseases(2025)10.1093/cid/ciaf298

N/A

0DataRank · unranked

1 citations

Sarah B. Doernberg, Dennis O. Dixon, Ramya Gopinath, Daniel B. Rubin, Tori Kinamon +10 more

A Qualitative Secondary Analysis of Patient Health-Related Quality of Life in Bloodstream Infections by Source: Intra-abdominal, Urinary Tract, and Acute Bacterial Skin and Skin Structure Infection

Clinical Infectious Diseases(2025)10.1093/cid/ciaf295

N/A

0DataRank · unranked

1 citations

Katherine Norman, Julie Miller, Hannah Lane, Julie Schexnayder, Megan Oakes +7 more

Patients’ Experiences With Staphylococcus aureus and Gram-negative Bacterial Bloodstream Infections: A Qualitative Descriptive Study and Concept Elicitation Phase To Inform Measurement of Patient-reported Quality of Life

Clinical Infectious Diseases(2020)10.1093/cid/ciaa611

N/A

0DataRank · unranked

31 citations

Sarah B. Doernberg, Julie J. Miller, Kiran Grover, Megan Oakes, Felicia Ruffin +12 more

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

PLoS ONE(2025)10.1371/journal.pone.0325561

N/A

0DataRank · unranked

0 citations

Greg Grandits, Robert C. Hyzy, Hallie C. Prescott, Thomas Barrett, Robin Dewar +24 more

Duration of antibiotic therapy for Staphylococcus aureus bacteraemia: the long and the short of it

Clinical Microbiology and Infection(2020)10.1016/j.cmi.2020.01.003

N/A

0DataRank · unranked

14 citations

Vance G. Fowler, Thomas L Holland, Emily M. Eichenberger

PROPHETIC

CHEST Journal(2020)10.1016/j.chest.2020.06.034

N/A

0DataRank · unranked

31 citations

Adrian Coles, Sara B. Calvert, John Farley, John H. Powers, Marcus Zervos +16 more

Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01060-21

N/A

0DataRank · unranked

19 citations

Gwendolyn Pais, Thomas P. Lodise, Steven Y. C. Tong, Joshua S. Davis, J. Nicholas O’Donnell +8 more

Patients’ Experiences With Staphylococcus aureus and Gram-Negative Bacterial Bloodstream Infections: Results From Cognitive Interviews to Inform Assessment of Health-Related Quality of Life

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab622

N/A

0DataRank · unranked

10 citations

Sarah B. Doernberg, Kiran Grover, Julie Miller, Megan Oakes, Tsai-Wei Wang +11 more